Permanently charged sodium and calcium channel blockers as antiinflammatory agents

Details for Australian Patent Application No. 2010271269 (hide)

Owner PRESIDENT AND FELLOWS OF HARVARD COLLEGE THE GENERAL HOSPITAL CORPORATION CHILDRENS' MEDICAL CENTER CORPORATION

Inventors Woolf, Clifford J.; Bean, Bruce P.

Agent Griffith Hack

Pub. Number AU-A-2010271269

PCT Pub. Number WO2011/006073

Priority 61/224,512 10.07.09 US

Filing date 9 July 2010

Wipo publication date 13 January 2011

International Classifications

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/006073 Priority application(s): WO2011/006073

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010271270-Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

2010271259-Bone conduction communications headset with hearing protection